カテゴリー： 世界, MarketsandMarkets

ゲノム編集の世界市場（～2029年）

【英語タイトル】Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (gRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-In), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) - Global Forecast to 2029

MarketsandMarketsが出版した調査資料（BT 3380）・商品コード：BT 3380
・発行会社（調査会社）：MarketsandMarkets
・発行日：2024年11月
・ページ数：480
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後1営業日）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,950 ⇒換算￥712,800見積依頼/購入/質問フォーム
Corporate License（法人閲覧用）USD8,150 ⇒換算￥1,173,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

世界の遺伝子編集市場は、2023年に約44億4,000万米ドル、2024年には46億6,000万米ドルと推定され、2029年までに年平均成長率（CAGR）10.2%で成長し、約75億9,000万米ドルに達すると予測されています。この成長は、技術革新、個別化医療の需要拡大、先天性疾患の増加などによって促進されています。一方で、オフターゲット効果や製造面の課題が大きな障壁となっています。

市場の主要成長地域は北米で、特にCRISPRやPrime editing、Bridge RNAといった先端技術の登場が注目されています。Prime editingはDNAの二重鎖切断なしに正確な遺伝子修復が可能で、副作用の軽減にも寄与します。Bridge RNAは大規模なDNA挿入を可能にし、編集精度を高める技術です。こうした技術は、稀少疾患やがんの治療応用にも期待が高まっています。

ただし、CRISPR-Cas9などでは意図しないDNA切断が起こる「オフターゲット効果」が懸念されており、安全性や倫理的問題、特に生殖細胞への編集は慎重な姿勢が求められています。さらに、製造工程の拡張性やCDMOでのスロット不足などにより、開発の遅延も発生しています。

製品技術ではCRISPRが最大のシェアを占めており、次いでTALENが続きます。主なプレイヤーには、Thermo Fisher、Merck、GenScript、Takara Bioなどが含まれます。ユーザー分類では、製薬・バイオテクノロジー企業が最大の利用者で、gRNA合成や細胞株開発など多様なサービスを利用しています。

地域別では北米が最大市場であり、NIHなどによる多額の研究支援が成長を後押ししています。アジア太平洋地域は今後最も急速に成長する市場とされており、日本、韓国、中国を中心に研究開発と技術導入が進んでいます。

最近の動向としては、AgilentによるBIOVECTRAの買収や、GenKOreとRevvityの共同研究、MerckによるMirus Bio買収などがあり、業界全体での統合と協業が活発化しています。今後も遺伝子編集技術の進化と応用拡大により、市場は大きな成長が見込まれています。

The global gene editing market, valued at US$4.44 billion in 2023, stood at US$4.66 billion in 2024 and is projected to advance at a resilient CAGR of 10.2% from 2024 to 2029, culminating in a forecasted valuation of US$7.59 billion by the end of the period. Market growth is attributed to factors such as advancements in gene editing technologies, the expanding range of gene editing applications, rising demand for personalized medicine, and the growing prevalence of congenital disorders. However, the market faces several challenges, including off-target effects of gene editing and issues with scalability and manufacturing, which pose significant hurdles.

The gene editing market ecosystem encompasses product, service, end user, and regulatory authorities. Gene Editing Product Providers create kits, reagents, software, and technologies like CRISPR and TALENs for gene editing. Gene Editing Service Providers provide unique gene editing, consulting, and technical assistance to clients who need customized solutions or lack in-house knowledge. Academic institutions, biotechnology, and pharmaceutical companies, and CROs use gene editing technologies and services for drug discovery, gene therapy development, and agricultural biotechnology. Their actions drive gene editing product and service demand. Gene editing products and services must meet safety, effectiveness, and ethical requirements set by regulators. These bodies regulate gene editing technology research and use, particularly in clinical and therapeutic settings. The gene editing market ecosystem is shaped by product, service, end user, and regulatory interactions.

The gene editing market is segmented into six major regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is the largest regional market for gene editing in 2023, while Europe is the second-largest market. The large share of North America can be attributed to the surge in development and approval of advanced therapies requiring gene editing products and services. However, The Asia Pacific is estimated to be the fastest-growing segment of the market characterized by a significant focus on R&D activities to broaden the scope of genomics applications, increasing adoption of genomics technologies for diagnostics, and technological developments in genomic data analysis. The gene editing market in the United States is distinguished by a collaborative environment, strong government support, major investment, and R&D initiatives. The US National Institutes of Health (NIH) has been a key driver, investing USD 814 million in gene editing projects as of September 2024, including the Somatic Cell Genome Editing (SCGE) program, which received more than USD 140 million in funding in July 2023 to accelerate genome editing from lab research to clinical applications. Furthermore, the NIH will provide USD 22 million to UC Berkeley and Ohio State University in July 2023 to explore CRISPR-based therapeutics for neurological illnesses, demonstrating the government’s commitment to promoting research.

DRIVER: Expanding scope of gene editing applications

Cell and gene therapies are advanced therapies used to treat a wide range of diseases such as cancer, cystic fibrosis, heart disease, and genetic disorders. Cell therapy is referred to a therapy in which viable cells are injected or implanted into patient’s body to get therapeutic effects. On the other hand, gene therapy is the medical technology used to produce therapeutic effect through manipulation of gene expressions. Thus, cell and gene therapies are widely used for the treatment of genetic and rare diseases. The adoption of cell & gene therapy has increased over the last few years, and this trend is expected to continue in the coming years due to the high and rising incidence of cancer and other rare diseases. For instance, to data released by GLOBOCAN in 2020, it was estimated that 19.3 million cases new cancer cases and 10.0 million cancer deaths occurred in 2020. The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020. Therefore, increasing need of cell & gene therapy due to rising prevalence of chronic diseases is propelling the growth of transfection technologies market.

RESTRAINT: Off-target effects and safety concerns.

Off-target effects and safety concerns limit gene editing market expansion. Despite its precision in gene editing, CRISPR-Cas9 encounters off-target DNA cleavage effects. The single-guide RNA (sgRNA) can guide the Cas9 enzyme to splice DNA at mistargeted locations in the genome. Such effects can cause non-specific and hazardous gene modifications, reducing gene editing’s therapeutic application. Many methods have been developed to decrease off-target effects, including sgRNA optimization, Cas9 nuclease modifications, and prime editors. These advancements are not failsafe, and off-target consequences remain a concern, especially in precision-driven therapeutics. The safety of gene editing extends beyond the patient to laboratory and clinical workers and close contacts. The use of viral vectors like adeno-associated viruses (AAVs) for gene delivery requires strict safety precautions to avoid genome integration or infection. Another ethical and safety issue is germline editing, which could affect future generations. These factors make the market cautious, restricting gene editing technology adoption until these hazards are known and managed.

KEY PLAYERS IN THE GENE EDITING MARKET INCLUDE

Thermo Fisher Scientific Inc. (US)
Merck KGaA (Germany)
GenScript (US)
Agilent Technologies, Inc. (US)
Revvity (US)
Lonza (US)
Tecan Trading AG (Switzerland)
Sangamo therapeutics (US)
Precision BioSciences (US)
Cellectis S.A. (France)
Regeneron Pharmaceuticals Inc. (US)
AMSBIO (UK)
Creative Biogene (US)
Synthego (US)
Takara Bio Inc. (Japan)
Bio-Techne (US)
Caribou Biosciences, Inc. (US)
Bioneer corporation (South Korea)
REPROCELL Inc. (Japan)

❖ レポートの目次 ❖

1. Introduction

2. Research Methodology

3. Executive Summary

4. Premium Insights

5. Market Overview

  • 5.1 Introduction

  • 5.2 Market Dynamics

    • Drivers

      • Increasing demand for personalized medicine

      • Government funding for gene editing projects

      • Expanding applications of gene editing

    • Restraints

      • Off-target effects and safety concerns

    • Opportunities

      • Technological advancements (prime editing, bridge RNA)

      • Increasing prevalence of congenital disorders

    • Challenges

      • Scalability issues in workflows

      • High equipment & manufacturing costs

  • 5.3 Market Trends & Disruptions

  • 5.4 Pricing Analysis

    • Price trends by consumables (2023)

    • Cost range for kits & reagents (2021–2023)

    • Service pricing trends by type and region

  • 5.5 Supply Chain Analysis

  • 5.6 Value Chain Analysis

  • 5.7 Ecosystem Analysis

  • 5.8 Impact of Generative AI

  • 5.9 Technology Analysis

    • Key Technologies: NGS, Electroporation, Microinjection

    • Complementary Technologies: Synthetic Biology, Data Analysis, HTS

    • Adjacent Technologies: Single-cell Analysis, Optogenetics, Gene Delivery

  • 5.10 Patent Analysis

  • 5.11 Key Conferences & Events (2024–2025)

  • 5.12 Regulatory Analysis

    • Regional Overview: North America, Europe, Asia Pacific

    • Regulatory Bodies and Agencies

  • 5.13 Porter’s Five Forces Analysis

  • 5.14 Key Stakeholders & Buying Criteria

  • 5.15 Case Studies

  • 5.16 Investment & Funding Landscape (2021–2024)

  • 5.17 Trade Data (Import/Export, 2019–2023)

6. Gene Editing Market by Offering

  • 6.1 Introduction

  • 6.2 Products

  • 6.3 Services

7. Gene Editing Products Market by Type

  • 7.1 Introduction

  • 7.2 Reagents & Consumables

    • Kits, Libraries, Reagents

  • 7.3 Software & Systems

8. Reagents & Consumables Market by Technique

  • 8.1 Introduction

  • 8.2 Knock-Out

  • 8.3 Knock-In

  • 8.4 Gene Silencing

  • 8.5 Other Techniques

9. Products Market by Technology

  • 9.1 Introduction

  • 9.2 CRISPR

  • 9.3 TALENs

  • 9.4 ZFN

  • 9.5 Base Editing

  • 9.6 Antisense

  • 9.7 RNAi

  • 9.8 Other Technologies

10. Products Market by Application

  • 10.1 Introduction

  • 10.2 Cell Line Engineering

  • 10.3 Genome Editing

  • 10.4 Drug Discovery & Development

  • 10.5 Other Applications

11. Products Market by End User

  • 11.1 Introduction

  • 11.2 Pharma & Biotech Companies

  • 11.3 Academic & Research Institutes

  • 11.4 CROs & CDMOs

  • 11.5 Other End Users

12. Gene Editing Services Market by Type

  • 12.1 Introduction

  • 12.2 Cell Line Development & Engineering

  • 12.3 gRNA Synthesis & Vector Construction

  • 12.4 Library Construction & Screening

  • 12.5 Other Services

13. Services Market by Application

  • 13.1 Introduction

  • 13.2 Cell Line Engineering

  • 13.3 Genome Editing

  • 13.4 Drug Discovery & Development

  • 13.5 Other Applications

14. Services Market by End User

  • 14.1 Introduction

  • 14.2 Pharma & Biotech Companies

  • 14.3 Academic & Research Institutes

  • 14.4 Other End Users

15. Gene Editing Market by Region

  • 15.1 Introduction

  • 15.2 North America

    • U.S., Canada

  • 15.3 Europe

    • Germany, France, UK, Italy, Spain, Rest of Europe

  • 15.4 Asia Pacific

    • China, Japan, India, South Korea, Australia, Rest of APAC

  • 15.5 Latin America

    • Brazil, Rest of Latin America

  • 15.6 Middle East

    • GCC, Rest of Middle East

  • 15.7 Africa

16. Competitive Landscape

  • 16.1 Introduction

  • 16.2 Strategies of Key Players (2021–2024)

  • 16.3 Revenue Analysis (2019–2023)

  • 16.4 Market Share Analysis (2023)

  • 16.5 Valuation & Financial Metrics

  • 16.6 Product/Brand Comparison

  • 16.7 Company Evaluation Matrix – Key Players

  • 16.8 Company Evaluation Matrix – Startups/SMEs

  • 16.9 Competitive Scenario (Launches, Deals, Expansions)

17. Company Profiles

  • 17.1 Key Players (Thermo Fisher, Merck, GenScript, etc.)

  • 17.2 Other Notable Companies

18. Appendix

  • 18.1 Discussion Guide

  • 18.2 KnowledgeStore Subscription Portal

  • 18.3 Customization Options

  • 18.4 Related Reports

  • 18.5 Author Details

LIST OF TABLES

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 2 GENE EDITING MARKET: RISK ASSESSMENT ANALYSIS
TABLE 3 GENE EDITING MARKET: IMPACT ANALYSIS
TABLE 4 APPROVALS FOR PERSONALIZED MEDICINE (GENE THERAPIES), 2023−2024
TABLE 5 PERSONALIZED MEDICINE APPROVALS (GENE THERAPIES) IN 2022
TABLE 6 AVERAGE COST RANGE OF GENE EDITING KITS & REAGENTS, 2021−2023
TABLE 7 AVERAGE SELLING PRICE, BY REGION, 2021−2023 (USD)
TABLE 8 COMMERCIALIZATION OF AI IN GENE EDITING
TABLE 9 GENE EDITING MARKET: KEY CONFERENCES & EVENTS, 2024–2025
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 GENE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 15 GENE EDITING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
TABLE 16 INVESTMENT & FUNDING ACTIVITIES, BY KEY PLAYER (2021−2024)
TABLE 17 IMPORT DATA FOR KITS & REAGENTS, BY REGION, 2019−2023 (USD)
TABLE 18 EXPORT DATA FOR KITS & REAGENTS, BY REGION, 2019−2023 (USD THOUSAND)
TABLE 19 GENE EDITING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 20 GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 21 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 22 EUROPE: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 23 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 24 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 25 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 26 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 27 GENE EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 28 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 33 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 35 GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 36 GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 37 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 EUROPE: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 42 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 GENE EDITING KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 44 NORTH AMERICA: GENE EDITING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 EUROPE: GENE EDITING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 ASIA PACIFIC: GENE EDITING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 LATIN AMERICA: GENE EDITING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 MIDDLE EAST: GENE EDITING KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 49 GCC COUNTRIES: GENE EDITING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 GENE EDITING LIBRARIES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 51 NORTH AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 EUROPE: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 ASIA PACIFIC: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 LATIN AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 MIDDLE EAST: GENE EDITING LIBRARIES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 56 GCC COUNTRIES: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 GENE EDITING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 58 NORTH AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 EUROPE: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 ASIA PACIFIC: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 LATIN AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 MIDDLE EAST: GENE EDITING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 63 GCC COUNTRIES: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
TABLE 65 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 EUROPE: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 69 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
TABLE 70 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 72 KNOCK-OUT TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 73 NORTH AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 74 EUROPE: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 ASIA PACIFIC: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 LATIN AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 MIDDLE EAST: KNOCK-OUT TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 78 GCC COUNTRIES: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 KNOCK-IN TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 80 NORTH AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 81 EUROPE: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 82 ASIA PACIFIC: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 LATIN AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 MIDDLE EAST: KNOCK-IN TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 85 GCC COUNTRIES: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 GENE SILENCING TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 87 NORTH AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 EUROPE: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 ASIA PACIFIC: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 LATIN AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 MIDDLE EAST: GENE SILENCING TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 92 GCC COUNTRIES: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 OTHER TECHNIQUES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 MIDDLE EAST: OTHER TECHNIQUES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 99 GCC COUNTRIES: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 100 GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 101 GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION, 2022–2029 (USD MILLION)
TABLE 102 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 EUROPE: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION, 2022–2029 (USD MILLION)
TABLE 107 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION, 2022–2029 (USD MILLION)
TABLE 109 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 EUROPE: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION, 2022–2029 (USD MILLION)
TABLE 114 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION, 2022–2029 (USD MILLION)
TABLE 116 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 EUROPE: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 120 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION, 2022–2029 (USD MILLION)
TABLE 121 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION, 2022–2029 (USD MILLION)
TABLE 123 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 EUROPE: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION, 2022–2029 (USD MILLION)
TABLE 128 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION, 2022–2029 (USD MILLION)
TABLE 130 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131 EUROPE: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION, 2022–2029 (USD MILLION)
TABLE 135 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION, 2022–2029 (USD MILLION)
TABLE 137 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 138 EUROPE: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 139 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 140 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION, 2022–2029 (USD MILLION)
TABLE 142 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 144 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 LATIN AMERICA: GENE EDITING GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 148 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 149 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150 GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 151 CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 152 NORTH AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 EUROPE: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 ASIA PACIFIC: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 155 LATIN AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 156 MIDDLE EAST: CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 157 GCC COUNTRIES: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 GENOME EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 159 NORTH AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 EUROPE: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161 ASIA PACIFIC: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 LATIN AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 163 MIDDLE EAST: GENOME EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 164 GCC COUNTRIES: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 166 NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 EUROPE: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 170 MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 171 GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) (USD MILLION)
TABLE 172 GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 173 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 177 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 178 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 179 GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 180 GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 181 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 EUROPE: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 184 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 186 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187 GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 188 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 EUROPE: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 192 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 193 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)
TABLE 195 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 EUROPE: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 198 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 199 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)
TABLE 200 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 201 GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 202 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 206 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 207 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 208 GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 209 CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 210 NORTH AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 211 EUROPE: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212 ASIA PACIFIC: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 213 LATIN AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 214 MIDDLE EAST: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 215 GCC COUNTRIES: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 217 NORTH AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 EUROPE: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 ASIA PACIFIC: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 220 LATIN AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 221 MIDDLE EAST: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 222 GCC COUNTRIES: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 224 NORTH AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 EUROPE: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 226 ASIA PACIFIC: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 227 LATIN AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 228 MIDDLE EAST: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 229 GCC COUNTRIES: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 230 GENE EDITING MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION)
TABLE 231 NORTH AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 EUROPE: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 234 LATIN AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 235 MIDDLE EAST: GENE EDITING MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION)
TABLE 236 GCC COUNTRIES: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 237 GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 238 CELL ENGINEERING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 239 NORTH AMERICA: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240 EUROPE: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 241 ASIA PACIFIC: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 242 LATIN AMERICA: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 243 MIDDLE EAST: CELL ENGINEERING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 244 GCC COUNTRIES: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 245 GENOME EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 246 NORTH AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 EUROPE: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 248 ASIA PACIFIC: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 LATIN AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 250 MIDDLE EAST: GENOME EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 251 GCC COUNTRIES: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 252 DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 253 NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 254 EUROPE: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 255 ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 256 LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 257 MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 258 GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 259 GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 260 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 261 EUROPE: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 262 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 263 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 264 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 265 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 266 GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 267 GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 268 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 269 EUROPE: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 270 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 271 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 272 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 273 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 274 GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 275 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 276 EUROPE: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 277 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 278 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 279 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 280 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 281 GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 282 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 283 EUROPE: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 284 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 285 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 286 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 287 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 288 GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 289 GENE EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 290 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 291 NORTH AMERICA GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 292 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 293 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 294 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 295 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 296 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 297 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 298 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 299 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 300 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 301 US: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 302 US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 303 US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 304 US: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 305 US: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 306 US: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 307 US: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 308 US: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 309 US: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 310 CANADA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 311 CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 312 CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 313 CANADA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 314 CANADA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 315 CANADA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 316 CANADA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 317 CANADA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 318 CANADA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 319 EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 320 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 321 EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 322 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 323 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 324 EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 325 EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 326 EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 327 EUROPE: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 328 EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 329 EUROPE: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 330 EUROPE: MACROECONOMIC INDICATORS
TABLE 331 GERMANY: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 332 GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 333 GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 334 GERMANY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 335 GERMANY: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 336 GERMANY: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 337 GERMANY: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 338 GERMANY: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 339 GERMANY: GENE EDITING SERVICES MARKET, BY END USERS, 2022–2029 (USD MILLION)
TABLE 340 FRANCE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 341 FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 342 FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 343 FRANCE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 344 FRANCE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 345 FRANCE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 346 FRANCE: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 347 FRANCE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 348 FRANCE: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 349 UK: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 350 UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 351 UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 352 UK: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 353 UK: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 354 UK: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 355 UK: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 356 UK: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 357 UK: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 358 ITALY: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 359 ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 360 ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 361 ITALY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 362 ITALY: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 363 ITALY: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 364 ITALY: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 365 ITALY: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 366 ITALY: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 367 SPAIN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 368 SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 369 SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 370 SPAIN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 371 SPAIN: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 372 SPAIN: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 373 SPAIN: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 374 SPAIN: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 375 SPAIN: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 376 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 377 REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 378 REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 379 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 380 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 381 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 382 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 383 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 384 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 385 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 386 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 387 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 388 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 389 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 390 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 391 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 392 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 393 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 394 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 395 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 396 ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 397 CHINA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 398 CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 399 CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 400 CHINA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 401 CHINA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 402 CHINA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 403 CHINA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 404 CHINA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 405 CHINA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 406 JAPAN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 407 JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 408 JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 409 JAPAN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 410 JAPAN: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 411 JAPAN: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 412 JAPAN: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 413 JAPAN: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 414 JAPAN: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 415 INDIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 416 INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 417 INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 418 INDIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 419 INDIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 420 INDIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 421 INDIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 422 INDIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 423 INDIA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 424 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 425 SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 426 SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 427 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 428 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 429 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 430 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 431 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 432 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 433 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 434 AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 435 AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 436 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 437 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 438 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 439 AUSTRALIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 440 AUSTRALIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 441 AUSTRALIA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 442 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 443 REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 444 REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 445 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 446 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 447 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 448 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 449 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 450 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 451 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 452 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 453 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 454 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 455 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 456 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 457 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 458 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 459 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 460 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 461 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 462 LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 463 BRAZIL: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 464 BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 465 BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 466 BRAZIL: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 467 BRAZIL: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 468 BRAZIL: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 469 BRAZIL: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 470 BRAZIL: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 471 BRAZIL: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 472 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 473 REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 474 REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 475 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 476 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 477 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 478 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 479 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 480 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 481 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 482 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 483 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 484 MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 485 MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 486 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 487 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 488 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 489 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 490 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 491 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 492 MIDDLE EAST: MACROECONOMIC INDICATORS
TABLE 493 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 494 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 495 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 496 GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 497 GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 498 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 499 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 500 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 501 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 502 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 503 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 504 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 505 KINGDOM OF SAUDI ARABIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 506 KINGDOM OF SAUDI ARABIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 507 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 508 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 509 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 510 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 511 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 512 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 513 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 514 UNITED ARAB EMIRATES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 515 UNITED ARAB EMIRATES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 516 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 517 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 518 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 519 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 520 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 521 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 522 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 523 OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 524 OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 525 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 526 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 527 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 528 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 529 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 530 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 531 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 532 REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 533 REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 534 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 535 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 536 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 537 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 538 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 539 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 540 AFRICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 541 AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 542 AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 543 AFRICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 544 AFRICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 545 AFRICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 546 AFRICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 547 AFRICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 548 AFRICA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 549 MACROECONOMIC OUTLOOK FOR AFRICA
TABLE 550 GENE EDITING MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021−2024
TABLE 551 GENE EDITING MARKET: DEGREE OF COMPETITION, 2023
TABLE 552 GENE EDITING MARKET: PRODUCT FOOTPRINT
TABLE 553 GENE EDITING MARKET: SERVICE FOOTPRINT
TABLE 554 GENE EDITING MARKET: TECHNOLOGY FOOTPRINT
TABLE 555 GENE EDITING MARKET: APPLICATION FOOTPRINT
TABLE 556 GENE EDITING MARKET: REGION FOOTPRINT
TABLE 557 GENE EDITING MARKET: KEY STARTUPS/SMES
TABLE 558 GENE EDITING MARKET: COMPETITIVE BENCHMARKING OF KEY START UPS/SMES
TABLE 559 GENE EDITING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–SEPTEMBER 2024
TABLE 560 GENE EDITING MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 561 GENE EDITING MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 562 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 563 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
TABLE 564 THERMO FISHER SCIENTIFIC INC.: PRODUCT APPROVALS/LAUNCHES, JANUARY 2021−SEPTEMBER 2024
TABLE 565 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 566 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 567 MERCK KGAA: COMPANY OVERVIEW
TABLE 568 MERCK KGAA.: PRODUCTS/SERVICES OFFERED
TABLE 569 MERCK KGAA: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 570 GENSCRIPT: COMPANY OVERVIEW
TABLE 571 GENSCRIPT.: PRODUCTS/SERVICES OFFERED
TABLE 572 GENSCRIPT: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–SEPTEMBER 2024
TABLE 573 GENSCRIPT: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 574 GENSCRIPT: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 575 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 576 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 577 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 578 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 579 REVVITY. INC. COMPANY OVERVIEW
TABLE 580 REVVITY, INC.: PRODUCTS/SERVICES OFFERED
TABLE 581 REVIVTY, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
TABLE 582 REVVITY, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 583 LONZA: COMPANY OVERVIEW
TABLE 584 LONZA: PRODUCTS/SERVICES OFFERED
TABLE 585 LONZA: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
TABLE 586 TECAN TRADING AG: COMPANY OVERVIEW
TABLE 587 TECAN TRADING AG: PRODUCTS/SERVICES OFFERED
TABLE 588 TECAN TRADING AG: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 589 SANGAMO THERAPEUTICS: COMPANY OVERVIEW
TABLE 590 SANGAMO THERAPEUTICS: PRODUCTS/SERVICES OFFERED
TABLE 591 SANGAMO THERAPEUTICS: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 592 PRECISION BIOSCIENCES: COMPANY OVERVIEW
TABLE 593 PRECISION BIOSCIENCES: PRODUCTS/SERVICES OFFERED
TABLE 594 PRECISION BIOSCIENCES: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 595 CELLECTIS S.A.: COMPANY OVERVIEW
TABLE 596 CELLECTIS S.A.: PRODUCTS/SERVICES OFFERED
TABLE 597 CELLECTIS S.A.: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 598 REGENERON PHARMACEUTICALS, INC.: COMPANY OVERVIEW
TABLE 599 REGENERON PHARMACEUTICALS INC.: PRODUCTS/SERVICES OFFERED
TABLE 600 REGENERON PHARMACEUTICALS, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 601 AMSBIO: COMPANY OVERVIEW
TABLE 602 AMSBIO: PRODUCTS/SERVICES OFFERED
TABLE 603 CREATIVE BIOGENE: COMPANY OVERVIEW
TABLE 604 CREATIVE BIOGENE: PRODUCTS/SERVICES OFFERED
TABLE 605 SYNTHEGO: COMPANY OVERVIEW
TABLE 606 SYNTHEGO: PRODUCTS/SERVICES OFFERED
TABLE 607 SYNTHEGO: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
TABLE 608 SYNTHEGO: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 609 SYNTHEGO: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 610 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 611 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
TABLE 612 TAKARA BIO INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 613 TAKARA BIO, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 614 BIO-TECHNE: COMPANY OVERVIEW
TABLE 615 BIO-TECHNE.: PRODUCTS/SERVICES OFFERED
TABLE 616 BIO-TECHNE: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 617 BIO-TECHNE: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 618 CARIBOU BIOSCIENCES, INC.: COMPANY OVERVIEW
TABLE 619 CARIBOU BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 620 CARIBOU BIOSCIENCES, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 621 BIONEER CORPORATION: COMPANY OVERVIEW
TABLE 622 BIONEER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 623 REPROCELL, INC.: COMPANY OVERVIEW
TABLE 624 REPROCELL, INC.: PRODUCTS/SERVICES OFFERED
TABLE 625 ALSTEM INC.: COMPANY OVERVIEW
TABLE 626 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
TABLE 627 INSCRIPTA, INC.: COMPANY OVERVIEW
TABLE 628 BIOCAT GMBH: COMPANY OVERVIEW
TABLE 629 INTEGRATED DNA TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 630 COBO TECHNOLOGIES APS.: COMPANY OVERVIEW
TABLE 631 GENECOPOEIA, INC.: COMPANY OVERVIEW
TABLE 632 HERA BIOLABS: COMPANY OVERVIEW
TABLE 633 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
TABLE 634 AXOL BIOSCIENCE LTD.: COMPANY OVERVIEW
TABLE 635 CELLECTA, INC.: COMPANY OVERVIEW
TABLE 636 APPLIED STEMCELL: COMPANY OVERVIEW



★調査レポート[ゲノム編集の世界市場（～2029年）] (コード：BT 3380)販売に関する免責事項を必ずご確認ください。
★調査レポート[ゲノム編集の世界市場（～2029年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の構造ヘルスモニタリング市場（～2029年）
  • 細胞・遺伝子治療製造サービスの世界市場レポート（2024年）
  • 細胞＆遺伝子治療CDMO市場-規模、シェア、動向分析レポート、予測2024-2030
  • エクソソーム研究市場～2030年までの世界予測
  • グローバル味覚センサーシステムに関する調査レポート
  • 塗料の世界市場
  • 世界のクラスDオーディオ・アンプ市場2023
  • フォースゲージの世界市場2023
  • 世界の木タール市場2023
  • 光学透明接着剤（OCA）の世界市場2023

    • ◆H&Iグローバルリサーチのお客様（例）◆